KRT7 and ependymoma: Ependymomas from different locations have been shown to present differential molecular manifestations in many validated molecular analyses, and the immunohistochemistry of myxopapillary ependymomas has been reported to be focally positive for CK AE1/AE3, CAM5.2, and CK7 [33,34].